Loading stock data…
AMS
$1.50+0.20 (+15.00%)
After Hours$1.51+0.01 (+0.87%)· Last close Jun 9
American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
American Shared Hospital Services in the Healthcare sector is trading at $1.50 with a market capitalization of $11M. Wall Street consensus targets $4.00 (1 analysts), implying a +167.6% move over the next 12 months. The stock is currently near its 52-week low of $1.25, remaining 26.4% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +167.6% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$1.50
Potential Downside
0%
Whystock Fair Value$1.50
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments: Leasing and Direct Patient Service. The company leases nine Gamma Knife ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$10.87M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.32
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-6.46%
Volume
Today's trading volume
554,592
Recent News
American Shared Hospital Services (AMS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...
AMS reports a 15.9% revenue increase and outlines plans for new facilities, despite ongoing net losses and higher operating costs.
American Shared Hospital Services Q1 2026 Earnings Call Summary
Moby summary of American Shared Hospital Services's Q1 2026 earnings call
JPMorgan Puts Spotlight On Ams OSRAM Micro LED AI Data Center Bet
ams-OSRAM (SWX:AMS) is accelerating its entry into AI data center markets through Micro LED technology. The company has announced a new commercialization partnership focused on AI data centers and optical networking. The AI focused opportunity is now expected to arrive earlier than previously anticipated for the Micro LED business. For investors watching SWX:AMS, this shift places more emphasis on the company’s Micro LED platform alongside its broader portfolio in sensing, illumination and...
Is It Time To Reassess ams-OSRAM (SWX:AMS) After Its Recent Share Price Surge?
Wondering if ams-OSRAM at CHF17.10 is offering genuine value or just riding a wave of excitement? This article walks through what the current price may be implying. The stock has seen sharp recent moves, with returns of 37.8% over 7 days, 64.3% over 30 days, 98.5% year to date and 112.4% over 1 year. This comes even though the share price has fallen 47.4% over 3 years and 81.5% over 5 years. These swings sit against a backdrop of ongoing attention on ams-OSRAM's role as a semiconductor...
Earnings Update: Here's Why Analysts Just Lifted Their ams-OSRAM AG (VTX:AMS) Price Target To CHF10.30
Shareholders will be ecstatic, with their stake up 38% over the past week following ams-OSRAM AG 's ( VTX:AMS ) latest...